Drug
Pyrithione Zinc
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Skin Fissures | 21 | 40.1 | 41.6 | signal |
| 2 | Dermatitis Atopic | 35 | 25.3 | 26.8 | signal |
| 3 | Hair Texture Abnormal | 9 | 24.0 | 24.4 | signal |
| 4 | Application Site Pain | 14 | 22.9 | 23.5 | signal |
| 5 | Skin Haemorrhage | 9 | 22.5 | 22.8 | signal |
| 6 | Scratch | 6 | 20.9 | 21.1 | signal |
| 7 | Application Site Rash | 7 | 18.3 | 18.5 | signal |
| 8 | Skin Exfoliation | 42 | 18.2 | 19.6 | signal |
| 9 | Eczema | 25 | 17.9 | 18.7 | signal |
| 10 | Pain Of Skin | 12 | 16.0 | 16.3 | signal |
| 11 | Dry Skin | 58 | 15.9 | 17.5 | signal |
| 12 | Pharyngeal Swelling | 4 | 15.1 | 15.2 | signal |
| 13 | Application Site Irritation | 5 | 14.5 | 14.6 | signal |
| 14 | Product Odour Abnormal | 4 | 13.9 | 14.0 | signal |
| 15 | Eye Pruritus | 11 | 12.0 | 12.2 | signal |
| 16 | Skin Irritation | 15 | 11.8 | 12.1 | signal |
| 17 | Hair Colour Changes | 4 | 11.5 | 11.5 | signal |
| 18 | Sleep Disorder Due To A General Medical Condition | 5 | 11.1 | 11.2 | signal |
| 19 | Application Site Erythema | 8 | 11.0 | 11.1 | signal |
| 20 | Drug Administered At Inappropriate Site | 3 | 10.1 | 10.2 | signal |
| 21 | Psoriatic Arthropathy | 10 | 9.0 | 9.1 | signal |
| 22 | Therapeutic Response Shortened | 7 | 7.9 | 8.0 | signal |
| 23 | Application Site Pruritus | 4 | 6.3 | 6.4 | signal |
| 24 | Skin Burning Sensation | 11 | 5.6 | 5.7 | signal |
| 25 | Product Preparation Error | 3 | 5.2 | 5.2 | signal |
| 26 | Exposure Via Skin Contact | 3 | 4.8 | 4.8 | signal |